MRNA

Value 202020212022202320242025 TTM Total revenue 803.39 M18.47 B19.26 B6.85 B3.24 B1.94 B 2.23 B Gross profit 795.46 M15.85 B13.85 B2.15 B1.77 B1.08 B 521 M Operating expenses 1.57 B5.17 B9.84 B11.09 B7.18 B4.15 B 3.25 B Selling/general/admin expenses 188.27 M567 M1.13 B1.75 B1.32 B1.15 B 965 M Research & development 1.37 B1.99 B3.29 B4.84 B4.54 B3.13 B 2.88 B Operating income -763.14 M13.3 B9.42 B-4.24 B-3.94 B-3.07 B -3.32 B Non-Operating Income, Total -53.84 M-65 M124 M323 M381 M365 M 282 M Interest expense, net of interest capitalized 9.89 M17 M29 M38 M24 M3 M — Non-Operating Income, excl. Interest Expenses -57.65 M-53 M140 M409 M444 M370 M 331 M Unusual income/expense -6.08 M-29 M-45 M-124 M-87 M-8 M -49 M Pretax income -744.51 M13.29 B9.57 B-3.94 B-3.61 B-2.77 B -3.09 B Equity in earnings ———-35 M-52 M-8 M -2 M Taxes 2.55 M1.08 B1.21 B772 M-46 M54 M 64 M Non-controlling/minority interest —————— — After tax other income/expense ——-28 M-7 M-60 M-77 M -51 M Net income before discontinued operations -747.06 M12.2 B8.36 B-4.71 B-3.56 B-2.82 B -3.15 B Discontinued operations —————— — Net income -747.06 M12.2 B8.36 B-4.71 B-3.56 B-2.82 B -3.15 B Dilution adjustment 0————— — Preferred dividends 0————— — Diluted net income available to common stockholders -747.06 M12.2 B8.36 B-4.71 B-3.56 B-2.82 B -3.15 B Basic earnings per share (Basic EPS) —30.3121.26-12.33-9.28-7.26 -7.98 Diluted earnings per share (Diluted EPS) —28.2920.12-12.33-9.28-7.26 -7.98 Average basic shares outstanding —403 M394 M382 M384 M389 M — Diluted shares outstanding —431 M416 M382 M384 M389 M — EBITDA -731.89 M13.53 B9.77 B-3.62 B-3.76 B-2.86 B -3.09 B EBIT -763.14 M13.3 B9.42 B-4.24 B-3.94 B-3.07 B -3.32 B Cost of revenue 7.93 M2.62 B5.42 B4.69 B1.46 B868 M 1.71 B Other cost of goods sold ——1.92 B2.34 B555 M315 M 297 M Depreciation & amortization (cash flow) 31.25 M232 M348 M617 M185 M211 M 229 M